196 related articles for article (PubMed ID: 7488490)
41. Atypical reactions to halothane in a subgroup of homozygous malignant hyperthermia(MH)-susceptible pigs: indication of a heterogenous genetic basis for the porcine syndrome.
Richter A; Gerdes C; Löscher W
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):401-6. PubMed ID: 1425316
[TBL] [Abstract][Full Text] [Related]
42. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Mortier W; Breucking E
Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
[TBL] [Abstract][Full Text] [Related]
43. Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine.
Wedel DJ; Gammel SA; Milde JH; Iaizzo PA
Anesthesiology; 1993 Jun; 78(6):1138-44. PubMed ID: 8512107
[TBL] [Abstract][Full Text] [Related]
44. Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals.
Chang L; Daly C; Miller DM; Allen PD; Boyle JP; Hopkins PM; Shaw MA
Br J Anaesth; 2019 May; 122(5):613-621. PubMed ID: 30916033
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine.
Roewer N; Dziadzka A; Greim CA; Kraas E; Schulte am Esch J
Anesthesiology; 1995 Jul; 83(1):141-59. PubMed ID: 7604993
[TBL] [Abstract][Full Text] [Related]
46. Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia.
Vellecco V; Mancini A; Ianaro A; Calderone V; Attanasio C; Cantalupo A; Andria B; Savoia G; Panza E; Di Martino A; Cirino G; Bucci M
Clin Sci (Lond); 2016 Jan; 130(1):35-44. PubMed ID: 26460077
[TBL] [Abstract][Full Text] [Related]
47. The effect of succinylcholine on malignant hyperthermia events in susceptible swine.
Schuster F; Johannsen S; Moegele S; Metterlein T; Roewer N; Anetseder M
BMC Anesthesiol; 2014 Mar; 14():14. PubMed ID: 24606822
[TBL] [Abstract][Full Text] [Related]
48. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
[TBL] [Abstract][Full Text] [Related]
49. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
50. In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia.
Freymond D; Dériaz O; Frascarolo P; Reiz S; Jéquier E; Urwyler A
Anesthesiology; 2000 Jul; 93(1):39-47. PubMed ID: 10861144
[TBL] [Abstract][Full Text] [Related]
51. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
Anderson IL; Jones EW
Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
[TBL] [Abstract][Full Text] [Related]
52. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
[TBL] [Abstract][Full Text] [Related]
53. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
54. Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia.
Metterlein T; Schuster F; Kranke P; Hager M; Roewer N; Anetseder M
Anesth Analg; 2011 May; 112(5):1174-8. PubMed ID: 21474662
[TBL] [Abstract][Full Text] [Related]
55. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
[TBL] [Abstract][Full Text] [Related]
56. Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.
Schuster F; Metterlein T; Negele S; Gardill A; Schwemmer U; Roewer N; Anetseder M
Anesthesiology; 2007 Oct; 107(4):616-20. PubMed ID: 17893458
[TBL] [Abstract][Full Text] [Related]
57. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.
Foster PS; Denborough MA
Br J Anaesth; 1989 May; 62(5):566-72. PubMed ID: 2730830
[TBL] [Abstract][Full Text] [Related]
58. [Contraction-relaxation coupling of skeletal muscle in patients susceptible to malignant hyperthermia].
Etchrivi TS; Adnet P; Haudecoeur G; Teneur F; Stix I; Krivosic-Horber RM
Ann Fr Anesth Reanim; 2002 Jun; 21(6):471-7. PubMed ID: 12134592
[TBL] [Abstract][Full Text] [Related]
59. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
Harrison GG; Dyer RA; Llewellyn RL; James MF
Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
[TBL] [Abstract][Full Text] [Related]
60. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
